GlassScriptPhysician profile
Neha Patel
NPI 1790133809
$745.40
in general payments reported to CMS, 2019-2025
18 companies · $565 in 2025
The $565 reported for 2025 was more than what 76% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $66.08 · 2022: $16.77 · 2023: $79.73 · 2024: $17.41 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $154.37 | 2025 | Freestyle Libre 3 |
| Pfizer INC. | $63.68 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $63.11 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $45.63 | 2020 | |
| Lilly USA, LLC | $44.17 | 2025 | Jardiance |
| Ardelyx, INC. | $42.92 | 2025 | Ibsrela |
| Amryt Pharma Holdings LTD | $42.86 | 2023 | Mycapssa |
| Glaxosmithkline, LLC. | $41.46 | 2025 | Trelegy Ellipta |
| Novo Nordisk INC | $40.33 | 2025 | Wegovy, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $36.23 | 2025 | |
| Astellas Pharma US INC | $35.29 | 2025 | Veozah |
| Cequr Corporation | $28.69 | 2025 | Cequr Simplicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.70 | 2023 | Xifaxan |
| Janssen Pharmaceuticals, INC | $20.45 | 2020 | |
| Aimmune Therapeutics, INC. | $17.41 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $16.77 | 2022 | |
| Abbvie INC. | $15.17 | 2023 | |
| Exact Sciences Corporation | $15.16 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.